Pages that link to "Item:Q2452091"
From MaRDI portal
The following pages link to Adaptive clinical trial designs for phase I cancer studies (Q2452091):
Displaying 7 items.
- Adaptive oncology Phase I trial design of drug combinations with drug-drug interaction modeling (Q1782097) (← links)
- On optimal designs for clinical trials: an updated review (Q2301225) (← links)
- Randomized phase II cancer clinical trials (Q2852232) (← links)
- A new design of the continual reassessment method (Q5082671) (← links)
- PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials (Q6047779) (← links)
- Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)